Recursion director sells 40K shares under plan
Recursion Pharmaceuticals director Christopher Gibson reported an exercise-and-sell style transaction involving 40,000 shares of Class A Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Recursion Pharmaceuticals director Christopher Gibson reported an exercise-and-sell style transaction involving 40,000 shares of Class A Common Stock. He converted 40,000 shares of Class B Common Stock into 40,000 Class A shares and then sold 40,000 Class A shares in an open-market transaction at $3.61 per share.
According to a footnote, this activity was carried out under a pre-arranged Rule 10b5-1 trading plan adopted by Gibson on May 12, 2025. After these moves, he holds 906,556 Class A shares directly, along with 4,403,334 Class B shares directly and additional Class B shares held indirectly through family entities.
Insider Trade Summary 10b5-1
Exercise and Sale: 40,000 shares ($144K approx. pre-tax spread)
Exercise and Sale
12 txns
Insider
Gibson Christopher
Role
Director
Sold
40,000 shs ($144K)
Approx. gross sale proceeds
$144K
Approx. exercise cost
$0.00
Approx. pre-tax spread
$144K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Class B Common Stock | 40,000 | $0.00 | $0.00 |
| Conversion | Class A Common Stock | 40,000 | $0.00 | $0.00 |
| Sale | Class A Common Stock | 40,000 | $3.61 | $144K |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Class B Common Stock — 4,403,334 contracts (Direct);
Class A Common Stock — 906,556 shares (Direct);
Class B Common Stock — 0 contracts (Indirect, by LAHWRAN-3 LLC);
Class B Common Stock — 0 contracts (Indirect, by LAHWRAN-4 LLC);
Class B Common Stock — 0 contracts (Indirect, by Gibson Family Trust);
Stock Option (Right to Buy) — 0 contracts (Direct)
Footnotes (10)
- F1. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
- F2. This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
- F3. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
- F4. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
- F5. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
- F6. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- F7. The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- F8. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- F9. The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- F10. The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Key Figures
Shares sold: 40,000 shares
Sale price: $3.61/share
Class A holdings after: 906,556 shares
+3 more
6 metrics
Shares sold
40,000 shares
Class A open-market sale at $3.61 per share
Sale price
$3.61/share
Price for 40,000 Class A shares sold
Class A holdings after
906,556 shares
Direct Class A Common Stock after reported transactions
Class B holdings after
4,403,334 shares
Direct Class B Common Stock after 40,000-share conversion
Converted shares
40,000 shares
Class B Common Stock converted into Class A
Net share change
-40,000 shares
Net buy/sell shares in transaction summary (net-sell)
Key Terms
Rule 10b5-1 trading plan, Class B Common Stock, derivative security, Stock Option (Right to Buy), +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Class B Common Stock financial
"Each share of Class B Common Stock is convertible into one share of Class A Common Stock"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
derivative security financial
"transaction_code_description": "Conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Stock Option (Right to Buy) financial
""security_title": "Stock Option (Right to Buy)""
open-market sale financial
""transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Christopher Gibson report in this Form 4 for RXRX?
Christopher Gibson reported converting 40,000 shares of Class B Common Stock into 40,000 Class A shares, then selling 40,000 Class A shares at $3.61 each. The activity reflects an exercise-and-sell pattern disclosed for Recursion Pharmaceuticals (RXRX).
How is Gibson’s indirect ownership in RXRX structured according to the filing?
The filing notes that some Class B shares are held indirectly through the Gibson Family Trust and LAHWRAN-3 and LAHWRAN-4 LLCs. Gibson is described as trustee or a member and manager of these entities, linking them to his broader Recursion Pharmaceuticals ownership.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates